# Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma

> **NCT07657494** · NA · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 94 (estimated)

## Conditions studied

- Aggressive Lymphoma

## Interventions

- **DRUG:** Al18F-NOTA-FAPI
- **DRUG:** Al18F-NOTA-grazytracer/68Ga-grazytracer

## Key facts

- **NCT ID:** NCT07657494
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-11
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657494, "Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07657494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*